This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoshioka, M. Articles by Finette, B. A. Search for Related Content PubMed PubMed Citation Articles by Yoshioka, M. Articles by Finette, B. A.

Gestational Age and Gender-specific In Utero V(D)J Recombinase-mediated Deletions¹

Department of Pediatrics [M. Y., B. A. F.], Genetics Laboratory [P. O.], Vermont Cancer Center [P. O., B. A. F.], Departments of Medical Biostatistics [P. M. V.] and Microbiology and Molecular Genetics [B. A. F.], University of Vermont, Burlington, Vermont 05405

Recent studies have brought to the forefront the importance of somatic mutations during human fetal development and malignant transformation in children, specifically leukemia. Therefore, a better understanding of the frequency and mutational spectrum of spontaneous in utero mutations is essential for understanding the genetic mechanisms associated with pediatric malignancies. Previously we reported that the frequency of somatic mutations during the late stages of fetal development was dependent on both gestational age and gender. Here we present the hypoxanthine-guanine phosphoribosyltransferase (HPRT) reporter gene mutational spectra analysis for 60 T-cell mutant isolates from the umbilical cord blood of preterm newborns to gain insight into background mutational events during the late stages of fetal development. Logistic regression analyses showed a significant increase in HPRT deletions mediated by V(D)J recombinase in preterm newborns compared with full-term newborns (P = 0.009). A comparative analysis of deletion mutations also revealed that V(D)J recombinase-mediated HPRT deletions increased with decreasing gestational age (P = 0.012) and were significantly higher in females than males of the same developmental status (P = 0.031). Developmental and gender-specific differences in HPRT deletions mediated by V(D)J recombinase provide insight into the gender-specific differences seen in infant leukemia.

This article has been cited by other articles:

				J. M. Murray, J. P. O'Neill, T. Messier, J. Rivers, V. E. Walker, B. McGonagle, L. Trombley, L. G. Cowell, G. Kelsoe, F. McBlane, et al. V(D)J Recombinase-Mediated Processing of Coding Junctions at Cryptic Recombination Signal Sequences in Peripheral T Cells during Human Development J. Immunol., October 15, 2006; 177(8): 5393 - 5404. [Abstract] [Full Text] [PDF]

				H. E. Kendall, P. M. Vacek, J. L. Rivers, S. C. Rice, T. L. Messier, and B. A. Finette Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia. Cancer Res., September 1, 2006; 66(17): 8455 - 8461. [Abstract] [Full Text] [PDF]

				J. L. Wiemels, Z. Xiao, P. A. Buffler, A. T. Maia, X. Ma, B. M. Dicks, M. T. Smith, L. Zhang, J. Feusner, J. Wiencke, et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia Blood, May 15, 2002; 99(10): 3801 - 3805. [Abstract] [Full Text] [PDF]